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Among 1316 rotavirus specimens collected during strain surveillance in the United States from 1996 to 1999, most strains
(95%) belonged to the common types (G1 to G4 and G9), while 5% were mixed infections of common serotypes, rare strains,
or not completely typeable. In this report, 2 rare (P[9],G3) and 2 partially typeable (P[6],G?; P[9],G?) strains from that study
were further characterized. The P[6] strain was virtually indistinguishable by hybridization analysis in 10 of its 11 gene
segments with recently isolated P2A[6],G9 strains (e.g., U.S.1205) from the United States, but had a distinct VP7 gene
homologous (94.7% aa and 90.2% nt) to the cognate gene from P1B[4],G12 reference strain L26. Thus, this serotype
P2A[6],G12 strain represents a previously unrecognized reassortant. Three P3[9] strains were homologous (97.8–98.2% aa)
in the VP8 region of VP4 to the P3[9],G3 feline-like reference strain AU-1, but had a high level of genome homology to Italian
bovine-like, P3[9],G3 and P3[9],G6 rotavirus strains. Two of the U.S. P3[9] strains were confirmed to be type G3 (97.2–98.2%
VP7 aa homology with reference G3 strain AU-1), while the other was most similar to Italian bovine-like strain PA151
(P3[9],G6), sharing 99.0% aa homology in VP7. Cross-neutralization studies confirmed all serotype assignments and
represented the first detection of these rotavirus serotypes in the United States. The NSP4 genes of all U.S. P3[9] strains and
rotavirus PA151 were most closely related to the bovine and equine branch within the DS-1 lineage, consistent with an animal
origin. These results demonstrate that rare strains with P and G serotypes distinct from those of experimental rotavirus
vaccines circulate in the United States, making it important to understand whether current vaccine candidates protect against
these strains. © 2002 Elsevier Science (USA)INTRODUCTION
Rotavirus is the most common etiologic agent of se-
vere diarrhea in children. More than 90% of infants have
experienced at least one rotavirus infection by 3 years of
age. It is estimated that 400,000 to 600,000 children die
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256from rotavirus infections each year worldwide (Kapikian
et al., 2001). In the United States, approximately 50,000
children are hospitalized due to rotavirus infections, and
nearly $1 billion in societal costs can be attributed to
rotavirus infections annually. Also, 20–40 infants die from
rotavirus disease yearly in the United States (Parashar et
al., 1997; Tucker et al., 1998). Good hygiene and sanita-
tion do not prevent the spread of rotavirus infections;
thus, vaccines to protect against or lessen the severity of
rotavirus disease are being developed.
Rotavirus is a triple-layered virus containing 11 gene
segments in its inner core. Each of these segments
codes for either structural or a nonstructural proteins of
which there are six each; gene segment 11 contains two
open reading frames (Estes, 2001). The outer capsid is
composed of two proteins, VP4 and VP7, that elicit a
neutralizing immune response, creating both serotype-
specific and cross-reactive immunity. Rotavirus serotype
classification is also based on these G (VP7 glycopro-Key Words: rotavirus; strain characterization; genotyping
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found in humans (Estes, 2001). The inner capsid of the
virus particle is composed of the VP6 protein, which
confers group and subgroup antigenicity used to classify
rotavirus (Estes, 1996). Group A strains commonly asso-
ciated with childhood diarrhea may possess subgroup I,
subgroup II, both subgroup I and subgroup II, or no
subgroup antigens (Kapikian et al., 2001). One nonstruc-
tural protein of importance is NSP4, which contains a
toxic peptide region, aa 114–135, that has been shown to
induce diarrheal disease in neonatal mice (Ball et al.,
1996) and has been hypothesized to play a role in the
pathogenesis of diarrhea in humans. Attenuation of virus
virulence may be associated with aa changes in the toxic
peptide region of the NSP4 gene (Zhang et al., 1998). The
NSP4 gene can be characterized by nt sequencing into
one of four NSP4 gene groups: Wa-like, DS-1-like, AU-1-
like, and EW-like strains (Ciarlet et al., 2000; Cunliffe et
al., 1997; Horie et al., 1999; Kirkwood and Palombo, 1997).
Experimental rotavirus vaccines have been designed
to provide specific immunity against one or multiple P
and G proteins in combination. Such vaccine strategies
have necessitated surveillance intensification worldwide
to document that the major antigens of experimental
vaccines are representative of the globally most common
strains. These studies have shown that serotypes G1, G3,
and G4 in combination with genotype P[8], and P[4],G2
strains continue to be the four most prevalent rotavirus
strains infecting humans (Gentsch et al., 1996; Woods et
al., 1992). Serotype combinations P[8],G9 and P[6],G9
appear to be emerging strains that since 1995 have been
identified in various parts of the world, including India,
the United States, Australia, Bangladesh, Brazil, Italy, the
United Kingdom, France, Japan, Ireland, Thailand, Viet-
nam, the Netherlands, and Malawi (Araujo et al., 2001;
Arista et al., 1997; Bon et al., 2000; Cubitt et al., 2000;
Cunliffe et al., 1999; Griffin et al., 2000; Maneekarn and
Ushijima, 2000; O’Halloran et al., 2000; Oka et al., 2000;
Palombo et al., 2000; Ramachandran et al., 1996, 1998;
Santos et al., 2001; Unicomb et al., 1999; Van Man et al.,
2001; Widdowson et al., 2001; Zhou et al., 2000). Strain
pattern prevalences may vary regionally, such as G5s in
Brazil, G8s in Brazil, Malawi, Egypt, Finland, and Ghana,
and G6s in Italy, Australia, and India (Armah et al., 2001;
Cunliffe et al., 1999; Gerna et al., 1990b, 1992; Holmes et
al., 1999; Kelkar and Ayachit, 2000; Leite et al., 1996;
Palombo and Bishop, 1995; Santos et al., 1998). RNA–
RNA hybridization, or genogrouping, has demonstrated
that some of the regionally common strains appear to
have resulted from in vivo reassortment between animal
rotaviruses especially of bovine and porcine origin and
human rotaviruses from the three main genogroups,
which are designated Wa, DS-1, and AU-1 (Alfieri et al.,
1996; Das et al., 1993; Dunn et al., 1993; Iizuka et al.,
1994; Nakagomi and Nakagomi, 1993).
The U.S. Strain Surveillance System, conducted by the
CDC, was initiated in anticipation of the national rotavi-
rus vaccination program (Ramachandran et al., 1998).
The first licensed vaccine, Rotashield, is a tetravalent
vaccine that contains rhesus rotavirus serotype G3 anti-
gens and human rotavirus serotype G1, G2, and G4
antigens (Kapikian et al., 1991). However, because of an
association with intussusception, the Rotashield vaccine
was suspended from the childhood vaccination sched-
ule, and the vaccine was withdrawn from the market
(Centers for Disease Control and Prevention, 1999a,b;
Murphy et al., 2001; Nakagomi, 2000). Nonetheless, the
emergence of serotype G9 as a possible fifth important G
serotype plus increased understanding of regional vari-
ation and lack of information on the ability of vaccines to
provide cross-reactive immunity further demonstrate the
important role of continued rotavirus strain surveillance.
Thus, the CDC has continued surveillance in the ab-
sence of a commercially available vaccine, but in antic-
ipation of continued vaccine trials with new candidate
vaccines, to evaluate rotavirus diversity, the presence of
rare strains, strain patterns and prevalence, and the
emergence of G9 strains. The surveillance project con-
ducted by the CDC has enlisted 10 to 12 hospitals geo-
graphically distributed throughout the continental United
States since 1996. During surveillance in the United
States from 1996 to 2000, serotype G1 was the predom-
inate strain followed by serotype G2, and the third most
common strain was serotype G9 (Griffin et al., 2000). For
4 years, more than 95% of strains were identified as the
common serotypes G1, G3, and G4 paired with P[8],
genotype combination P[4],G2, and the recurring sero-
type G9 strains in combination with P[8] or P[6]. The
remaining 5% were unusual combinations of common G
serotypes and P genotypes, G and/or P mixed infections,
rarely identified genotype P[9] strains, and G nontype-
ables (GNTs). There were two GNTs which could be P
genotyped, one as P[9] and one as P[6]. These two GNTs
along with the two P[9],G3 strains were cultivated in
MA104 cells and analyzed by sequencing, genogrouping,
and fluorescence focus reduction neutralization (FFN) for
full characterization. This report details the analysis of
these unusual strains collected in the United States.
RESULTS
VP7 sequence analysis
Strains Se584 (genotype P[9], long E-type, subgroup I
antigens) and Se585 (genotype P[6], short E-type, sub-
group I antigens) could not be G serotyped in our routine
monoclonal antibody (MAb) serotyping assay or G geno-
typed using reverse transcription-polymerase chain re-
action (RT-PCR) (Griffin et al., 2000). For these two
strains, it was necessary to sequence the VP7 gene to
determine their G genotypes. For comparison, the VP7
gene of the two strains CC425 and KC814 (P[9],G3, long
E-type, subgroup I antigens), identified by MAb enzyme
immunoassay (EIA) and RT-PCR as serotype G3, were
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also sequenced. Partial nt and deduced aa sequences of
the VP7 gene for each of these strains were obtained:
Se584 (908 nt, 301 aa), Se585 (970 nt, 326 aa), CC425
(1009 nt, 326 aa), and KC814 (1007 nt, 326 aa). This
analysis showed that strain Se584 is most closely re-
lated to strain PA151, a serotype G6 strain isolated in
Italy, sharing 96.3% nt and 99.0% aa homology, whereas
strain Se585 is most similar to strain L26, a serotype G12
strain identified in the Phillippines, sharing 90.2% nt and
94.7% aa homology (Table 1). The G3 strains CC425 and
KC814 are extremely homologous in their VP7 nt (99.5%)
and aa (99.0%) sequences to each other and exhibited
the most similarity to the G3 reference strain AU-1 (91%
nt, 97–98% aa), an isolate from Japan.
The VP7 antigenic regions (A, B, C, and F) of these
strains were compared with those of strains having the
same G genotype (data not shown). Se584 demonstrated
1 aa substitution in each antigenic region, A, B, and C,
when compared with human serotype G6 strain PA151,
whereas 2 to 4 aa substitutions were seen in all anti-
genic regions, A, B, C, and F, when compared with
serotype G6 bovine strain NCDV. Strain Se585 exhibited
an identical antigenic B region when compared with
serotype G12 reference strain L26 together with 1 or 2 aa
substitutions in antigenic regions A, C, and F. In contrast,
the two G3 strains CC425 and KC814 shared identical
antigenic regions A, B, and F and had only 1 aa substi-
tution in region C when compared to the VP7 gene
sequence of strain AU-1.
VP4 sequence analysis
The P genotypes of strains Se584, Se585, CC425, and
KC814 were identified by RT-PCR. To confirm the P ge-
notype assignment of these strains and to compare their
relationships to other human rotavirus P serotypes and
genotypes, sequence analysis of the VP8 portion of the
VP4 gene was carried out. The strains were compared
with one another and with standard human strains of
various P genotypes [4, 6, 8, 9, 10, 14] (Table 2). The U.S.
P[9] strains (Se584, CC425, and KC814) share approxi-
mately 96–98% nt and aa homology with strain P3[9]
AU-1. The P[6] genotype of strain Se585 was confirmed
when it was demonstrated to have 95% nt and aa identity
with strain ST-3, P2A[6],G4. It also shares 99.3% VP4 nt
and aa homology with strain US1205, a P2A[6],G9 iso-
lated in the United States in 1997 (data not shown). This
close relationship was also reflected in the phylogenetic
analysis wherein Se585 clustered tightly with US1205 and
other recent isolates possessing P[6] specificity (Fig. 1).
NSP4 sequence analysis
The potential role of NSP4 in virulence makes it an
important gene to study; therefore the NSP4 nt and
TABLE 1
Percentage of VP7 nt and aa Homology of Four US Rotavirus Strains to One Another and to Standard Strains G1 to G14
Rotavirus
straina G serotype
Sequence homology (%) of U.S. virus strains
CC425 KC814 Se584 Se585
nt aa nt aa nt aa nt aa
CC425 3 100.0 100.0 — — — — — —
KC814 3 99.5 99.0 100.0 100.0 — — — —
Se584 6 77.2 90.0 77.5 90.3 100.0 100.0 — —
Se585 12 74.5 89.2 74.8 89.2 73.6 85.2 100.0 100.0
Wa 1 74.7 87.7 74.7 87.7 72.5 84.6 74.5 84.2
S2 2 73.7 81.9 73.9 81.6 73.2 80.9 72.2 81.4
AU-1 3 91.3 97.2 91.8 98.2 76.0 89.6 74.5 88.2
ST3 4 74.2 83.1 74.4 83.1 74.7 85.6 72.3 81.4
OSU 5 77.1 88.3 77.3 88.7 75.8 87.6 75.1 86.1
PA151 6 78.9 90.2 79.0 90.5 96.3 99.0 74.5 86.1
Ty-1 7 64.9 70.6 65.3 70.9 65.3 71.9 64.3 67.7
69M 8 75.6 89.0 75.9 88.7 73.0 87.3 72.6 84.2
WI61 9 79.4 90.2 79.8 90.8 74.2 87.6 76.3 88.2
Mc35 10 75.8 88.3 76.0 88.7 74.3 87.3 79.1 84.2
YM 11 77.1 90.2 77.2 90.2 75.6 88.6 73.4 86.1
L26 12 75.5 86.5 75.8 87.4 73.2 83.6 90.2 94.7
L338 13 76.0 86.2 76.5 86.5 74.2 84.6 75.1 84.8
FI23 14 79.7 88.7 79.9 89.6 73.1 86.6 74.9 84.5
Note. Boldface type indicates high strain homology typically shared among strains of the same G serotype.
a The VP7 sequences were obtained from published reports and the GenBank database by accession number: Wa (K02033), S2 (M11164), AU-1
(D86271), ST3 (X13603), OSU (X04613), PA151 (L20881), Ty-1 (L01098), 69M (Green et al., 1989), WI61 (Green et al., 1989), Mc35 (D14033), YM (M23194),
L26 (M58290), L338 (D00843), FI23 (M61876).
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deduced aa sequences were analyzed for strains Se584,
Se585, CC425, and KC814. In addition, the NSP4 se-
quences for strains PA151 and L26 were determined in
this report. In contrast to their AU-1-like VP8 gene frag-
ments, the NSP4 genes of the U.S. P[9] strains (Se584,
CC425, and KC814) and PA151 segregated with the DS-1
lineage by phylogenetic analysis (Fig. 2). However, there
are several distinct sublineages supported by bootstrap
analysis among DS-1-like NSP4 genes, including one
represented by U.S. P[9] strains CC425, KC814, and
Se584 and a second represented by equine strains H2,
FI23, and FI14 (Fig. 2). The deduced aa sequences of the
NSP4 gene of the U.S. P[9] strains CC425 and KC814
were identical to each other and shared 99.4% identity
with strain Se584. These strains were more closely re-
lated to the NSP4 gene of PA151 and equine and bovine
strains including NCDV (96.0 to 97.1% aa identity) than to
other NSP4 genes within the DS-1 lineage (94.3–95.4%)
(data not shown). Consistent with the phylogenetic anal-
ysis, these two sublineages were characterized by 3–6
aa substitutions conserved within the group but not
present in other members of the DS-1 lineage (data not
shown). The U.S. P[6],G12 strain Se585 belonged to the
third and largest DS-1-like NSP4 gene sublineage which
included other recent isolates, such as US1205 and
US1250 (P2A[6],G9), and G2 reference strains such as S2
and KUN. The NSP4 gene of strain L26 appears to be
most like the NSP4 gene of strain 1076 (P2A[6],G2),
which is also found in the DS-1-like cluster.
Antigenic characterization
Two of the three P[9] strains, CC425 and KC814, were
identified originally as serotype G3 by MAb EIA that we
routinely use for serotyping our rotavirus positive speci-
mens. The third P[9] strain, Se584, was closely related to
serotype G6 by sequence analysis and confirmed as
serotype G6 by reactivity with G6 MAb IC-3 utilized in our
standard EIA format. We were unable to obtain a G
serotype for strain Se585 by our routine MAb EIA. This
was not unexpected since sequencing demonstrated
this strain to belong to genotype G12 and we do not have
a MAb with this specificity. The three long electrophero-
type P[9] strains and the short electropherotype P[6]
strain possessed subgroup I antigens.
To confirm the P and G serotypes, FFN was performed
on cultivated strains CC425, Se584, and Se585 using
hyperimmune antisera raised against 16 strains repre-
senting 14 distinct G serotypes (data not shown). Strain
CC425 was neutralized by hyperimmune antisera to se-
rotype G3 strains P and RRV to titers of 10,240 and
40,960, respectively. Antisera to serotype G6 strains UK
and NCDV neutralized strain Se584 to titers of 40,960
and 10,240, respectively. The G12 serotype-specificity of
Se585 was confirmed when it was neutralized to a titer of
10,240 by antisera created against L26.
The P serotypes of strains CC425 and Se584 were
confirmed to be P3[9] when these strains were neutral-
ized by antisera raised against reassortants PA151xDS-1
and K8xDS-1 to titers of 10,240 and 2560, respectively
(data not shown). Antisera against reassortant ST3xDS-1
neutralized strain Se585 to a titer of 1280, confirming that
this strain belongs to serotype P2A[6]. Together these
results demonstrate that the complete serotype designa-
tions of these strains are CC425, P3[9],G3; Se584,
P3[9],G6; and Se585, P2A[6],G12. The finding that CC425
belongs to serotype P3[9] strongly suggests that KC814
possesses the same P serotype since the deduced aa
TABLE 2
Sequence Comparison of the VP4 Gene of U.S. Rotavirus Strains with the Corresponding Sequences of Standard Rotavirus Strains
Straina P genotype
Sequence homology (%) of U.S. virus strains
CC425 KC814 Se584 Se585
nt aa nt aa nt aa nt aa
CC425 [9] 100 100 — — — — — —
KC814 [9] 99.5 99.6 100 100 — — — —
Se584 [9] 98.3 99.6 98.6 99.3 100 100 — —
Se585 [6] 60.9 62.4 61.4 62.3 60.7 62.4 100 100
DS-1 [4] 60.2 62.8 60.5 63.1 60.5 63.0 68.7 75.0
ST3 [6] 59.8 61.7 60.7 62.4 59.7 61.9 95.2 96.7
Wa [8] 59.6 62.5 60.6 63.5 60.0 62.3 71.4 76.1
AU-1 [9] 97.4 98.2 96.6 97.9 96.5 97.8 60.9 62.7
69M [10] 62.4 67.3 62.6 67.5 62.2 67.7 64.6 67.8
Mc35 [14] 77.7 89.9 77.6 89.8 77.6 89.6 58.5 61.6
Note. Boldface type indicates high strain homology typically shared among strains of the same P genotype.
a VP4 sequences from standard strains were obtained from the GenBank database using accession numbers DS-1, P11196; ST3, L33895; Wa,
M96825; AU-1, D10971; 69M, M60600; Mc35, D14032.
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homology between the VP8 regions of the two strains is
99.6%.
Genogrouping
The U.S. P3[9] strains had either serotype G3 or G6
specificity and a VP8 region closely related to AU-1,
raising the possibility that these strains could be closely
related to the feline rotavirus-like AU-1 reference strain.
However, previously described strains with these sero-
types from Italy (serotype P3[9],G3 and P3[9],G6) have
been shown to be reassortants between an AU-1-like
strain and a bovine-like strain. To determine whether the
U.S. P3[9] strains would show similar relationships, a
total genome probe produced from AU-1 was used for
genogrouping experiments. When the AU-1 probe was
hybridized with the U.S. P3[9] strains CC425, KC814, and
Se584, only four, four, and three bands were formed,
respectively (Fig. 3). This result suggested that these
strains were reassortants between the AU-1 genogroup
and another genetic lineage, such as the bovine-like
P3[9] strains isolated in Italy that gave a similar hybrid-
ization pattern with AU-1 probes (Iizuka et al., 1994;
Nakagomi et al., 1992a). To test this, we made probes to
bovine strain NCDV, which previously had reacted
strongly with P[9],G3 and P[9],G6 strains from Italy. As we
hypothesized, the NCDV probe was more homologous to
the U.S. P3[9] strains, forming five or six strong hybrid
bands and one to three intermediate or weak bands with
each strain (seven bands with CC425 and KC814 and
eight bands with Se584).
Total genome probes made from U.S. strains CC425,
Se584, and KC814 were hybridized to AU-1, bovine NCDV,
and representative Italian bovine-like P[9],G3 (PCP5) and
P[9],G6 (PA151) strains (Fig. 4; data from KC814 probe
experiments are not shown). As predicted, the CC425
and KC814 probes formed four bands with AU-1 while the
FIG. 1. Phylogenetic tree of VP4 deduced amino acid sequences. The tree was constructed using the PaupSearch Program of the Genetics
Computer Group (GCG) Sequence Analysis Software Suite (Devereux et al., 1984) using the neighbor-joining method and a multiple sequence format
file constructed with the PILEUP program of GCG as input. The distance between aa sequences is expressed as the number of aa substitutions per
site and is proportional to the horizontal distance between sequences. Only bootstrap probabilities greater than 90 out of 100 are given. An asterisk
denotes U.S. strains sequenced in this report. The following VP4 sequences were taken from the GenBank database (accession numbers): Mc35
(D14032), AU-1 (D10971), AU720 (D14618), RO5193 (X90733), K8 (D90260), RO6460 (X90736), MZ58 (D14622), PA151 (D14623), PCP5 (D14624), FRV1
(D10970), AU228 (D14615), RO5829 (X90734), Cat2 (D13403), 02-92 (AB008289), US1205 (AF079356), MW23 (AJ278253), GR630/86 (AF161825), HN221
(L20878), M37 (L20877), VE7156 (L25265), NNB1 (AF076926), ST-3 (L33895), 1076 (M88480), AU19 (AB017917), Gottfried (M33516), and 4F (L10359). G?,
we were unable to find a reference to the G type for strain HN221.
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Se584 probe formed three bands with AU-1, and all three
probes from the U.S. strains formed eight bands with
NCDV. These strains exhibited significant homology with
the Italian bovine-like strains, sharing at least seven or
eight gene segments with each. No significant hybrid
bands were formed between the U.S. P3[9] strains and
standard human strains DS-1 and Wa (data not shown).
Genogrouping of Se585 (P2A[6],G12) was also con-
ducted. As expected from its genotypic properties, Se585
shares 10 of its 11 gene segments with U.S. DS-1 geno-
group strain US1205, a P2A[6],G9 isolated in 1997, (Fig. 5)
and 7 gene segments with G12 strain L26 (data not
shown). Both Se585 and US1205 share multiple bands
with strain DS-1 (data not shown). Few or no hybrid
bands were seen when the Se585 probe was hybridized
with representative strains of NCDV, OSU, AU-1, and Wa.
DISCUSSION
Rotavirus continues to be a devastating disease
among children, and the best hope for its prevention is
the development of an effective vaccine. Rotavirus sur-
veillance is a necessary step in designing vaccines and
vaccine strategies to identify regional strain patterns and
potential emerging strains. During routine rotavirus sur-
veillance in the United States, a novel reassortant
P2A[6],G12, having a VP7 gene not previously seen in a
short E-type strain, and several rare P3[9],G6 and
P3[9],G3 isolates, which have not been previously iso-
lated in the United States, were found (Table 3). Because
of potential implications for rotavirus vaccine programs,
these unusual strains were characterized in detail by the
use of MAb EIA, RT-PCR, sequencing of the VP4, VP7,
and NSP4 genes, FFN, and RNA–RNA hybridization. Se-
FIG. 2. Phylogenetic tree of NSP4 deduced amino acid sequences. The tree was constructed using the PaupSearch program of the Genetics
Computer Group (GCG) Sequence Analysis Software Suite (Devereux et al., 1984) using the neighbor-joining method and a multiple sequence format
file constructed with the PILEUP program of GCG as input. The distance between aa sequences is expressed as the number of aa substitutions per
site and is proportional to the horizontal distance between sequences. Only bootstrap probabilities greater than 90 out of 100 are given. An asterisk
indicates U.S. strains sequenced in this report. The following NSP4 sequences were taken from the GenBank database (accession numbers): EHP
(U96336), EC (U96337), EW (AB003805), Wa (K02032), ST-3 (U59110), VA70 (U83798), H1 (AF144800), OSU (D88831), YM (X69485), 116E (U78558), RV-3
(U42628), M37 (U59109), AU32 (D88830), US1099 (AJ236759), US1205 (AF079358), US1250 (AJ236756), KUN (D88829), SA11 (K01138), UK (K03384), RV-5
(U59103), 1076 (U59105), NCDV (X06806), H2 (AF144801), FI23 (AF144802), FI14 (AF144803), FRV-1 (D89874), AU-1 (D89873), R2 (AB005472), RRV
(L41247), FRV64 (D88833), and RS15 (D88832). The P serotype of strain R-2 may be P11? (Estes, 2001).
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rotype G12 has been documented only once previously
(in the Philippines) in children with diarrhea. The refer-
ence G12 strain, L26, belonged to serotype P1B[4],G12
and had SG I antigens and a long E type (Taniguchi et al.,
1990). On the other hand, P3[9] strains are more widely
distributed. These strains have been identified in a vari-
ety of countries including Japan, Malaysia, Brazil, Vene-
zuela, Italy, Israel, South Africa, Guinea-Bissau, and now
in the United States (Fischer et al., 2000; Gerna et al.,
1990a, 1992; Griffin et al., 2000; Leite et al., 1996;
Nakagomi et al., 1987; Rasool et al., 1993; Santos et al.,
2001; Shif et al., 1994; Steele et al., 1993). Serotype G6
strains were originally isolated from diarrheic calves and
were thought to be unique to the bovine species
(Kapikian and Chanock, 1990; Snodgrass et al., 1990).
Later, G6 strains were detected in humans in Italy, Aus-
tralia, and India (Gerna et al., 1992; Kelkar and Ayachit,
2000; Palombo and Bishop, 1995). The detection and
characterization of these U.S. G6 strains have broadened
our knowledge of their global distribution and have con-
tributed to our understanding of the diversity of strains
circulating in the United States.
Since rotavirus has 11 gene segments, the theoretical
possibility of reassortment or exchange of gene seg-
ments between two or more strains during a mixed
infection is great. However, in early studies, natural re-
assortants between, for example, subgroup I strains
(usually G2 with short electropherotypes) and subgroup
II strains (usually G1, G3, or G4 with long electrophero-
type) were rarely detected by RNA–RNA hybridization
experiments, suggesting that rotavirus genes are genet-
ically linked (Nakagomi et al., 1987). In addition, reas-
sortment between subgroup I and subgroup II strains
could be obtained in vitro only at low frequency, which
supported the hypothesis that rotavirus genes are linked
in some cases (Garbarg-Chenon et al., 1984).
Studies using RNA–RNA hybridization assays applied
to larger numbers of human rotavirus strains have in
general supported these early findings (Flores et al.,
1982; Nakagomi and Nakagomi, 1993). Using radioactive
or digoxigenin-labeled total genome probes synthesized
by in vitro transcription or cDNA synthesis, the genetic
relatedness of RNAs from new strains can be compared
with RNA from reference strains on the basis of the
number of visible bands formed after hybridization with
the desired probes. An increasing number of hybrid
bands and comigration of hybrid bands of test strains
with homologous hybrids indicate a higher level of ge-
netic homology (Nakagomi and Nakagomi, 1991;
Nakagomi et al., 1992b; Ward et al., 1990). Most human
rotaviruses can be divided into one of two major geno-
groups, Wa or DS-1, or one minor genogroup, AU-1, on
the basis of overall genomic RNA homology (Nakagomi
et al., 1989). Reassortants between genogroups have
been described occasionally; however, in some regions,
intergenogroup reassortment may occur at high fre-
quency (Nakagomi and Nakagomi, 1991; Nakagomi et al.,
1992b; Palombo et al., 1996; Ramachandran et al., 2000;
Unicomb et al., 1999; Ward et al., 1990). In addition,
several rotavirus reassortants have been described that
have been derived from strains of human and animal
origin. This mechanism appears to be important for gen-
FIG. 3. Hybridization patterns between RNAs from rotavirus strains
listed at the top and RNA 32P-labeled probes listed at the bottom. The
top gel (a) has been stained with ethidium bromide and visualized with
UV light. The bottom gel (b) is the corresponding autoradiogram.
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eration of genetic diversity in rotaviruses (Alfieri et al.,
1996; Browning et al., 1992; Das et al., 1993; Holmes et
al., 1999; Urasawa et al., 1993).
Strain Se585 (P2A[6],G12) appears to be a naturally
occurring reassortant between a serotype G12 strain
such as L26 (P1B[4],G12) and a strain closely related to
FIG. 4. Hybridization patterns between RNAs from rotavirus strains listed at the top and RNA 32P-labeled probes listed at the bottom. The top gel
(a) has been stained with ethidium bromide and visualized with UV light. The bottom gel (b) is the corresponding autoradiogram.
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the DS-1 genogroup isolate US1205 (P2A[6],G9) (Kirk-
wood et al., 1999). The VP7 gene sequence of Se585
exhibited the most similarity to the VP7 gene sequence
of strain L26 and was neutralized by antisera against
strain L26. The VP4 gene sequence of strain Se585 was
highly homologous with the VP4 gene sequence of strain
US1205. When these two P2A[6] strains were compared
in a phylogenetic tree with other representative P[6]
strains, they segregated with recently described reassor-
tant MW23 (P2A[6],G8) from Malawian children and hu-
man South African strain GR630 (P2A[6],G4) within the
P2A[6] subtype cluster (Cunliffe et al., 2000; Pager et al.,
2000). Genogroup analysis demonstrated that Se585 and
US1205 are virtually indistinguishable with the exception
of the VP7 gene. Thus, both the relatively common short
electropherotype G9 strains isolated over the past sev-
eral years in the United States and perhaps elsewhere
(Ramachandran et al., 2000; Unicomb et al., 1999) and the
rare G12 strain appear to be single-segment (VP7 gene)
reassortants of a closely related parental virus from the
DS-1 genogroup. The G serotype of the short E-type
parent and the strains that donated the VP7 genes are
not known. Nonetheless, these studies suggest that the
short electropherotype profile strain may have an un-
usual propensity for generating new serotype combina-
tions by VP7-gene and/or VP4-gene replacement (Cun-
liffe et al., 2000; Ramachandran et al., 2000). Similar
mechanisms have been proposed for the generation of
the highly prevalent short electropherotype P2A[6],G8
strains from Malawi (Cunliffe et al., 2000).
The P3[9] strains described here are genetically more
similar to the P3[9] strains isolated in Italy than to the
AU-1-like P3[9] strains characterized in Japan (Gerna et
al., 1990a, 1992). The P3[9],G3 strains PCP5 and PA151
collected in Italy were demonstrated by genogrouping to
be reassortants between bovine and AU-1-like strains
(Iizuka et al., 1994; Nakagomi et al., 1992a). Interestingly,
the genomes of the U.S. P3[9] strains were more homol-
ogous with Italian P3[9] strains than with other reference
strains, and their homology with strains NCDV and AU-1
was similar to that reported for the Italian P3[9] strains
(Iizuka et al., 1994; Nakagomi et al., 1992a). Previous
reports suggest that P3[9] strains can be further classi-
fied into three subgenogroups on the basis of RNA–RNA
hybridization and VP8 sequence homology. As shown by
Gollop et al. (1998), using Israeli strains RO5193, RO6460,
and RO5829, strains that are more genetically similar,
sharing 11 of 11 gene segments with AU-1, tend to share
higher VP8 sequence similarity. This VP8 sequence iden-
tity decreases as the number of hybrid bands shared
with AU-1 declines (Gollop et al., 1998). We did not find
this association in our VP8 sequence analysis. These
three U.S. P3[9] strains did form a separate VP4 cluster
among the P3[9] strains even though they shared 96–
98% nt and aa homology with the AU-1 strain, confirming
and extending an observation that the P3[9] gene is
highly homogeneous irrespective of the year and place
of isolation or of the host species (Isegawa et al., 1992;
Nakagomi et al., 1993).
The NSP4 genes of P3[9] strains CC425, KC814, Se584,
and PA151 do not segregate into the AU-1-like NSP4
group but, consistent with the relationships of these
FIG. 5. Hybridization patterns between RNAs from rotavirus strains
listed at the top and RNA 32P-labeled probes listed at the bottom. The
top gel (a) has been stained with ethidium bromide and visualized with
UV light. The bottom gel (b) is the corresponding autoradiogram.
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strains to animal rotaviruses by genogrouping, are most
closely related to equine and bovine strains in the DS-
1-like NSP4 group. The NSP4 genes of the U.S. P3[9]
strains and the equine strains clustered in distinct sub-
lineages of the DS-1 NSP4 gene lineage. Also, there
were no remarkable changes in the toxic peptide region
among the U.S. P3[9] strains and AU-1 and NCDV.
The strains described in this report caused severe ill-
ness in children ages 1–8 years old (two P3[9] strains were
from 8- and 7-year-old children, respectively, while the third
P3[9] strain and the G12 isolate were from 1-year-old chil-
dren) who sought medical attention at a hospital. It is
unusual that children over 5 years old contract and develop
serious rotavirus disease since more than 90% of children
less than 3 years old have had at least one rotavirus
infection, which often protects against serious disease dur-
ing the second infection (Kapikian et al., 1996). The mean
and median ages of these four children (4.25 and 4 years,
respectively) are older than the overall study set (1.5 years
and 1 year, respectively). Thus, it is interesting to speculate
that the P3[9],G3 and P3[9],G6 strains caused secondary
infections in these older children because one or both of
the VP4 and VP7 neutralization antigens were distinct from
those of common human rotaviruses, allowing escape from
immunity and subsequent disease. Studies with larger
numbers of rare and novel strains will be necessary to
assess the significance of this difference. Serotype G12 has
been identified only once before in humans from the Phil-
ippines and was identified for the first time in the United
States (Taniguchi et al., 1990). Strain WI61, P[8],G9, was first
detected in the United States approximately 15 years ago
and was not identified again until 1995 (Clark et al., 1987);
however, serotype G9 now represents the third most com-
mon G serotype in this country (Griffin et al., 2000; Ram-
achandran et al., 1998). It will be important to continue to
monitor rotavirus strains in the future to detect emerging
strains and to determine effective vaccine strategies.
MATERIALS AND METHODS
Viruses
Rare strains were isolated from stool specimens col-
lected at hospital laboratories participating in the Na-
tional Rotavirus Surveillance System established by the
CDC in 1996 (Griffin et al., 2000; Ramachandran et al.,
1998). Strain CC425 was identified during the 1997–1998
rotavirus season in Texas, and strains KC814, Se584, and
Se585 were isolated in 1998–1999 in the states of Mis-
souri and Washington. Each specimen was prepared as
a 10% stool/PBS extract after clarification with Freon.
Samples were screened by EIA (Rotaclone, Meridian
Diagnostics) for the presence of rotavirus. Of these, 1316
positive specimens subsequently were subjected to G-
typing by EIA and/or RT-PCR and P-typing by RT-PCR.
G-nontypeables were amplified by RT-PCR for nt se-
quencing. These novel strains were activated with tryp-
sin and passaged three times in roller tubes of monkey
kidney cells (MA104) and two times in stationary flasks.
All passages were cultivated with 1 g/ml trypsin in the
maintenance medium. For genogrouping and neutraliza-
tion studies, the viruses were also plaque-purified and
further passaged before testing. The origins of reference
strains Wa, DS-1, P, AU-1, RRV, ST-3, OSU, UK, NCDV,
PA151, PCP5, Ch2, 69M, WI61, B223, YM, L26, L338, and
FI23 have been described previously (Arias et al., 1989;
Bohl et al., 1984; Browning et al., 1991a,b; Clark et al.,
1987; Gerna et al., 1990a, 1992; Matsuno et al., 1985;
McNulty et al., 1979; Mebus et al., 1971; Nakagomi et al.,
1987; Piec and Palombo, 1997; Stuker et al., 1980; Ura-
sawa et al., 1990; Wen et al., 1995; Woode et al., 1975,
1983; Wyatt et al., 1983, 1984).
Serotyping EIA
To G-serotype rotavirus strains, MAbs KU-4 (G1), 5E8
(G1), IC10 (G2), S2-SG10 (G2), YO-1E2 (G3), G3-159 (G3),
ST-2G7 (G4), and F45:8 (G9) were utilized in a modified
assay previously described (Coulson et al., 1987; Tanigu-
chi et al., 1987). Subgrouping was performed, using
MAbs 255/60 (subgroup I) and 631/9 (subgroup II), simul-
taneously with G-serotyping (Greenberg et al., 1983). To
serotype strain Se584, MAb IC3 (G6) was incorporated
into our standard assay (Snodgrass et al., 1990). A sero-
type or subgroup was assigned by a twofold higher
optical density value against the homologous MAb com-
TABLE 3
Summary of Properties of U.S. Strains Se584, Se585, KC814, and CC425
Strain
Characteristic (gene segment encoded by)
P serotype (4)
G serotype
(7, 8, or 9) E type (11) SG (6) Genogroup (1–11)
CC425 P3[9] 3 Long I Human AU-1/bovine
KC814 P3[9] 3 Long I Human AU-1/bovine
Se584 P3[9] 6 Long I Human AU/bovine
Se585 P2A[6] 12 Short I Human DS-1
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pared to the heterologous MAb reactions (Taniguchi et
al., 1987).
Electropherotypes
RNA was extracted from fecal specimens by the glass
powder method or from cell lysates by phenol–chloro-
form followed by the glass powder method (Gentsch et
al., 1992). To examine RNA profiles of viruses, RNA ex-
tracts were electrophoresed on 10% polyacrylamide gels.
Silver staining was applied to visualize bands as previ-
ously described (Merril et al., 1981).
RT-PCR
Rotavirus dsRNA was extracted from stool specimens
by use of the glass powder method in the presence of 4
M guanidine thiocyanate and from infected MA104 cells
by use of phenol–chloroform and precipitation by ethanol
followed by the glass powder procedure (Gentsch et al.,
1992). Identification of G and P types for some strains
was done utilizing primers in a seminested RT-PCR (Das
et al., 1994; Gentsch et al., 1992; Gouvea et al., 1990). The
VP8 section of the VP4 gene was amplified using the
consensus primers Con2 and Con3 (Gentsch et al.,
1992). To amplify the VP7 gene, degenerate beg9 and
end9 primers were used (Gouvea et al., 1990). A reaction
contained 10 pmol each of beg9 homologous to strains
Wa and S2 VP7 nt 1–27 and 4 pmol each of end9 com-
plementary to nt 1036–1062 of reference strains Wa (G1),
S2 (G2), and ST3 (G4) and recent isolates 92A (G2,
Accession No. U73947) and 95-91 (G3, Accession No.
D86266) (Piec and Palombo, 1997; Wen et al., 1995).
Nucleotide and amino acid sequencing
The QIAquick Gel Extraction Kit (Qiagen, Chatsworth,
CA) procedure was used to purify 1.2% SeaKem GTG
agarose gel (FMC Bioproducts, Rockland, ME) RT-PCR
products stained with ethidium bromide. DNA sequenc-
ing was performed on an automated sequencer (Applied
Biosystems Model 377), using the dideoxynucleotide
chain termination method and the Prism Ready Big Dye
Terminator Cycle Sequencing Kit (PE Applied Biosys-
tems, Foster City, CA). Internal primers were synthesized
for VP4 and VP7 genes on the basis of sequences ob-
tained from the original consensus primers. These oli-
gonucleotide primers were synthesized in the CDC Bio-
technology Core Facility. Overlapping sequence frag-
ments were analyzed manually using the Sequencher
program (Gene Codes Corp., Inc., Ann Arbor, MI) and
subsequently compared using the PILEUP and distances
programs of the University of Wisconsin Genetics Com-
puter Group software suite (Devereux et al., 1984).
The new nucleotide sequences described in this pa-
per have been submitted to the EMBL Nucleotide Se-
quence Database. The accession numbers for the NSP4
nucleotide sequences of strains L26 and PA151 are
AJ311732 and AJ311733, respectively. The accession
numbers of the VP7, VP4, and NSP4 nucleotide se-
quences follow: for strain CC425, they are AJ311738,
AJ311734, and AJ311728, respectively; for strain KC814,
they are AJ311739, AJ311735, and AJ311729, respectively;
for strain Se584, they are AJ311740, AJ311736, and
AJ311730, respectively; and for strain Se585, they are
AJ311741, AJ311737, and AJ311731, respectively.
FFN
FFN was incorporated to characterize the antigenic
VP4 and VP7 phenotypes of the tissue culture-adapted
strains as previously described (Coulson et al., 1985;
Hoshino et al., 1984). The reciprocal of the dilution giving
a 60% reduction in the number of infected cells com-
pared with that in the virus control wells was used to
express the neutralizing antibody titer. The preparation
and specificity of antisera to reassortant strains
WaxDS-1, S2xUK, DS-1xRRV, ST3xDS-1, PA151xDS-1,
K8xDS-1, K8xDS-1, and 69MxDS-1 and to reference
strains belonging to serotypes G1 to G14 have been
described previously (Hoshino and Kapikian, 1996;
Hoshino et al., 1984).
Genogroup analysis
Probes were synthesized against the novel U.S. tissue
culture-adapted strains and other standard strains for
hybridization comparisons as previously described (Na-
kagomi and Nakagomi, 1993; Nakagomi et al., 1989). In
brief, rotavirus RNA was transcribed in vitro in the pres-
ence of 32P-labeled GTP. The RNA was denatured for
hybridization experiments. The denatured RNA and
probes were mixed and allowed to hybridize for 16 h at
65°C and then analyzed by polyacrylamide gel electro-
phoresis. Genomic dsRNA was visualized by UV light
after ethidium bromide staining. Hybrids between the
probe RNA plus strands and the unlabeled minus
strands of the individual isolates were visualized by
autoradiography and compared with homologous reac-
tions to determine the overall genomic RNA constellation
reactions.
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